Srdjan R. Stankovic's Net Worth
$12.3 Million
Who is Srdjan R. Stankovic?
Srdjan R. Stankovic has an estimated net worth of $12.3 Million. This is based on reported shares across multiple companies, which include ACADIA PHARMACEUTICALS INC, and NEUROGEN CORP.
SEC CIK
Srdjan R. Stankovic's CIK is 0001432545
Past Insider Trading and Trends
2021 was Srdjan R. Stankovic's most active year for acquiring shares with 15 total transactions. Srdjan R. Stankovic's most active month to acquire stocks was the month of March. 2020 was Srdjan R. Stankovic's most active year for disposing of shares, totalling 20 transactions. Srdjan R. Stankovic's most active month to dispose stocks was the month of March. 2021 saw Srdjan R. Stankovic paying a total of $3,034,632.48 for 277,076 shares, this is the most they've acquired in one year. In 2020 Srdjan R. Stankovic cashed out on 537,693 shares for a total of $13,196,474.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.75% | 4.4K |
$15.07 | -$27,834.29 | 61.23K |
Nov 19 - Nov 21
| |||
Form 4
| +2.98% | 1.64K |
$15.81 | -$20,964.06 | 56.83K |
Oct 15
| |||
Form 4
| +13.94% | 6.75K |
$18.18 | -$52,090.86 | 55.19K |
Apr 29 - May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
| +7.59% | 3.42K |
$23.80 | -$35,723.80 | 48.44K |
Feb 23
| |||
Form 4
| +8.45% | 3.51K |
$23.05 | -$44,647.85 | 45.02K |
Jan 6
| |||
Form 4
| +9.06% | 3.45K |
$19.01 | -$53,285.03 | 41.51K |
Nov 19 - Nov 22
| |||
Form 4
| +4.48% | 1.63K |
$17.41 | -$23,294.58 | 38.06K |
Oct 15 - Oct 18
| |||
Form 4
| +17.34% | 5.38K |
$20.33 | -$85,995.90 | 36.43K |
Apr 29 - Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +53.35% | 10.8K |
$50.61 | -$426,591.69 | 31.05K |
Feb 4
| |||
Form 4
|
—
|
0
|
$36.57 | -$25,823.00 | 20.25K |
Scheduled
|
Jan 12
| ||
Form 4
| +22.50% | 3.72K |
$44.10 | -$5,130,030.62 | 20.25K |
Scheduled
|
Jan 6 - Jan 8
| ||
Form 4
| +27.08% | 3.52K |
$53.50 | -$145,948.00 | 16.53K |
Nov 19 - Nov 20
| |||
Form 4
| +14.75% | 1.67K |
$42.56 | -$55,200.32 | 13.01K |
Oct 15 - Oct 16
| |||
Form 4
|
—
|
0
|
$34.35 | -$2,580,437.16 | 11.33K |
Scheduled
|
Jun 18 - Jun 19
| ||
Form 4
| +88.05% | 5.31K |
$49.21 | -$211,996.68 | 11.33K |
Apr 29 - Apr 30
| |||
Form 4
|
—
|
0
|
$35.37 | -$557,024.96 | 6.03K |
Scheduled
|
Apr 23
| ||
Form 4
|
—
|
0
|
$34.90 | -$4,684,400.27 | 6.03K |
Scheduled
|
Apr 20 - Apr 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
| +211.15% | 4.09K |
$46.41 | -$100,245.60 | 6.03K |
Nov 19
| |||
Form 4
|
∞
| 1.94K |
$39.65 | -$40,879.15 | 1.94K |
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEUROGEN CORP No price found
Exec VP and CDO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||